Filter
559
Filtered Results: 559
Text search:
European
Medicines
Agency
EMA
Featured
Recommendations
65
New Publications
122
Language
Document type
No document type
265
Studies & Reports
114
Guidelines
95
Manuals
33
Fact sheets
23
Strategic & Response Plan
14
Situation Updates
5
Training Material
4
Brochures
2
Resource Platforms
2
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
29
Ukraine
13
Kenya
11
Global
11
Eastern Europe
11
Germany
10
Nigeria
9
Sierra Leone
8
Ethiopia
8
Liberia
8
Myanmar / Burma
8
Ghana
7
Africa
7
Zambia
7
Tanzania
6
South Africa
6
Syria
5
Uganda
5
India
5
Nepal
4
Guinea
4
Eastern Europe and Central Asia
4
Brazil
4
Indonesia
4
Tajikistan
3
Albania
3
Malawi
3
Zimbabwe
3
Philippines
3
Venezuela
3
Latin America and the Carribbean
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Bangladesh
3
Namibia
3
Yemen
3
Colombia
2
Serbia
2
Lesotho
2
Rwanda
2
Estonia
2
Cambodia
2
Jordan
2
Moldova
2
Russia
2
Georgia
2
South Sudan
2
Eswatini/ Swaziland
2
North Macedonia
1
Thailand
1
El Salvador
1
China
1
Kazakhstan
1
Chile
1
Cameroon
1
Iran
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Morocco
1
Mongolia
1
Armenia
1
USA
1
Haiti
1
Saudi Arabia
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Egypt
1
Sudan
1
Greece
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Ecuador
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
132
Clinical Guidelines
72
Women & Child Health
34
Key Resources
31
Public Health
28
Pharmacy & Technologies
12
Capacity Building
5
Toolboxes
COVID-19
61
AMR
48
HIV
42
Mental Health
41
TB
38
Rapid Response
34
Planetary Health
23
Pharmacy
22
Ebola & Marburg
21
Disability
17
Refugee
16
Conflict
15
NTDs
14
Global Health Education
12
Caregiver
10
Specific Hazards
8
Malaria
8
Zika
8
NCDs
3
Natural Hazards
2
Cholera
2
Polio
2
Social Ethics
1
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
This report explores the reasons why global health is critical to medicine and what this means for medical education. It argues that an understanding of global health is important for all students and practicing doctors, rather than being an ‘add-on’ or ‘option’ for specialization.
This guideline covers making people aware of how to correctly use antimicrobial medicines (including antibiotics) and the dangers associated with their overuse and misuse. It also includesmeasures to prevent and control infection that can stop people needing antimicrobials or spreadinginfection to o...
Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK.
'Health and human rights in the new world (dis)order' outlines a shifting rights landscape in which new ...
This document provides guidance to Member States in the WHO European Region that wish to conduct behavioural insights studies related to COVID-19. Studies can be used to monitor public knowledge, risk perceptions, behaviours and trust with the overall aim to inform national COVID-19 outbreak respons...
Assessment of the quality of institutional care for adults with psychosocial and intellectual disabilities in the WHO European Region.
The specific objectives of the project were to address gaps in knowledge about the number and characteristics of such long-term institutions and to identify deficie...
To test for ethnic discrimination in access to outpatient health care services, we carry out
an email-correspondence study in Germany. We approach 3,224 physician offices in the 79
largest cities in Germany with fictitious appointment requests and randomized patients’
characteristics. We find t...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
This report provides an overview of the operations and activities of the WHO Country Office in Ukraine in 2023. Despite the acute health impacts of the war in Ukraine, the Country Office continued its work according to its core mandate. WHO supported the Government of Ukraine in managing the health ...
Monitoring financial protection and utilization of health services in Mongolia 2009-2018 is based on national representative household socioeconomic surveys. The study finds that between 2009 and 2018, despite ambitious health reforms, the incidence of catastrophic health spending and impoverishing ...
This guide is a resource for future health professionals who want to learn about and engage in abortion issues. Abortion is a critical but often neglected area of women’s rights, women’s health and health science education. The guide ences students was developed for health sciences students -inc...
Despite some improvements, current levels of air pollution still pose a considerable risk to the environment and to human health in the WHO European Region. One issue of concern is that monitoring of particulate matter is very limited in the countries of eastern Europe, the Caucasus and central Asia...
Every day in 2020, approximately 800 women died from preventable causes related to pregnancy and childbirth - meaning that a woman dies around every two minutes.
Sustainable Development Goal (SDG) target 3.1 is to reduce maternal mortality to less than 70 maternal deaths per 100 000 live births by ...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
In the last five years, i.e. how old turned the Campaign “Indifesa” (Defenceless) in 2016, that was launched by Terre des Hommes in 2012, the world has become smaller. One can actually say that the derangements following the Arab Spring in 2011 reshuffled what is stable and what produces instabi...
